Shree Ganesh [SGRL] vs Suven Life Sciences [SUVEN] Detailed Stock Comparison

Shree Ganesh

BSE
Loading...

Suven Life Sciences

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Shree Ganesh wins in 11 metrics, Suven Life Sciences wins in 7 metrics, with 0 ties. Shree Ganesh appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricShree GaneshSuven Life SciencesBetter
P/E Ratio (TTM)30.84-28.01Suven Life Sciences
Price-to-Book Ratio4.6540.49Shree Ganesh
Debt-to-Equity Ratio26.440.00Suven Life Sciences
PEG Ratio-1.19-0.34Shree Ganesh
EV/EBITDA17.58-23.32Suven Life Sciences
Profit Margin (TTM)20.16%84.44%Suven Life Sciences
Operating Margin (TTM)19.77%-2,791.92%Shree Ganesh
EBITDA Margin (TTM)19.77%N/AN/A
Return on Equity15.89%-146.15%Shree Ganesh
Return on Assets (TTM)12.02%-118.91%Shree Ganesh
Free Cash Flow (TTM)$74.69M$-1.91BShree Ganesh
1-Year Return-38.00%46.77%Suven Life Sciences
Price-to-Sales Ratio (TTM)6.22641.26Shree Ganesh
Enterprise Value$6.85B$43.40BSuven Life Sciences
EV/Revenue Ratio6.32577.38Shree Ganesh
Gross Profit Margin (TTM)64.62%100.00%Suven Life Sciences
Revenue per Share (TTM)$84$0Shree Ganesh
Earnings per Share (Diluted)$17.03$-8.15Shree Ganesh
Beta (Stock Volatility)0.200.86Shree Ganesh
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Shree Ganesh vs Suven Life Sciences Stock Performance Analysis

Loading Price Chart...

Shree Ganesh
Suven Life Sciences
Shree Ganesh Stock Overview | Suven Life Sciences Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Shree Ganesh-3.10%-2.27%-14.23%-10.95%-31.40%-22.63%
Suven Life Sciences0.80%-0.17%-3.10%-15.83%58.82%63.15%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Shree Ganesh-38.00%112.42%294.53%1,442.27%1,442.27%1,442.27%
Suven Life Sciences46.77%186.97%307.88%-25.87%594.28%3,728.07%

News Based Sentiment: Shree Ganesh vs Suven Life Sciences

Shree Ganesh

News based Sentiment: NEGATIVE

September brought disappointing financial results for Shree Ganesh Remedies, with a significant decline in net profit. Coupled with leadership changes and a falling stock price, the month paints a concerning picture for investors, suggesting potential challenges ahead despite a discounted valuation compared to peers.

View Shree Ganesh News Sentiment Analysis

Suven Life Sciences

News based Sentiment: POSITIVE

The month of October 2025 saw Suven Life Sciences benefit from both company-specific gains and a broader pharmaceutical rally, indicating a positive trend for the company. The Pfizer agreement acted as a catalyst for this positive movement, suggesting a favorable market environment.

View Suven Life Sciences News Sentiment Analysis

Performance & Financial Health Analysis: Shree Ganesh vs Suven Life Sciences

MetricSGRLSUVEN
Market Information
Market Cap i₹6.85B₹48.20B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i6,495185,019
90 Day Avg. Volume i4,949147,095
Last Close₹508.95₹208.70
52 Week Range₹494.95 - ₹950.00₹102.50 - ₹299.99
% from 52W High-46.43%-30.43%
All-Time High₹950.05 (Jul 22, 2024)₹338.50 (Apr 13, 2015)
% from All-Time High-46.43%-38.35%
Growth Metrics
Quarterly Revenue Growth-0.01%0.86%
Quarterly Earnings Growth-0.26%0.86%
Financial Health
Profit Margin (TTM) i0.20%0.84%
Operating Margin (TTM) i0.20%-27.92%
Return on Equity (TTM) i0.16%-1.46%
Debt to Equity (MRQ) i26.440.00
Cash & Liquidity
Book Value per Share (MRQ)₹113.00₹5.04
Cash per Share (MRQ)₹22.01₹2.75
Operating Cash Flow (TTM) i₹337.14M₹-1,590,282,000
Levered Free Cash Flow (TTM) i₹230.68M₹-1,607,450,000
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend i₹0.00₹0.00

Valuation & Enterprise Metrics Analysis: Shree Ganesh vs Suven Life Sciences

MetricSGRLSUVEN
Price Ratios
P/E Ratio (TTM) i30.84-28.01
Forward P/E iN/A10.55
PEG Ratio i-1.19-0.34
Price to Sales (TTM) i6.22641.26
Price to Book (MRQ) i4.6540.49
Market Capitalization
Market Capitalization i₹6.85B₹48.20B
Enterprise Value i₹6.85B₹43.40B
Enterprise Value Metrics
Enterprise to Revenue i6.32577.38
Enterprise to EBITDA i17.58-23.32
Risk & Other Metrics
Beta i0.200.86
Book Value per Share (MRQ) i₹113.00₹5.04

Financial Statements Comparison: Shree Ganesh vs Suven Life Sciences

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)SGRLSUVEN
Revenue/Sales i₹246.68M₹18.67M
Cost of Goods Sold i₹87.28M₹0
Gross Profit i₹159.40M₹18.67M
Research & Development iN/A₹414.88M
Operating Income (EBIT) i₹48.77M₹-521.17M
EBITDA i₹79.58M₹-501.49M
Pre-Tax Income i₹45.98M₹-515.17M
Income Tax i₹11.53M₹0
Net Income (Profit) i₹34.45M₹-515.17M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)SGRLSUVEN
Cash & Equivalents i₹99.43M₹150.26M
Total Current Assets i₹775.75M₹754.72M
Total Current Liabilities i₹161.82M₹234.86M
Long-Term Debt i₹296.08MN/A
Total Shareholders Equity i₹1.45B₹1.10B
Retained Earnings i₹1.10B₹-6.01B
Property, Plant & Equipment i₹31.57M₹756.69M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)SGRLSUVEN
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricSGRLSUVEN
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i6,495185,019
Average Daily Volume (90 Day) i4,949147,095
Shares Outstanding i12.84M218.07M
Float Shares i2.20M67.61M
% Held by Insiders i0.76%0.69%
% Held by Institutions i0.00%0.02%

Dividend Analysis & Yield Comparison: Shree Ganesh vs Suven Life Sciences

MetricSGRLSUVEN
Last 12-Month Dividend i₹0.00₹0.00
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend i₹0.33₹0.00
3-Year Avg Dividend Yield i0.15%N/A
3-Year Total Dividends i₹1.00₹0.00
Ex-Dividend DateSep 07, 2023N/A